ALAGILLE SYNDROME
Clinical trials for ALAGILLE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ALAGILLE SYNDROME trials appear
Sign up with your email to follow new studies for ALAGILLE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare liver disease: drug may delay surgery in kids
Disease control Recruiting nowThis study follows 30 people with Alagille syndrome, a rare liver disease that causes severe itching and growth problems, as they take the drug odevixibat in real life. Researchers want to see if the medicine helps patients avoid major surgeries like bile duct rerouting or liver …
Matched conditions: ALAGILLE SYNDROME
Sponsor: Ipsen • Aim: Disease control
Last updated May 26, 2026 10:29 UTC
-
New study tracks Long-Term safety of livmarli in rare liver disease patients
Disease control Recruiting nowThis study follows about 100 people with Alagille syndrome who are taking the medication Livmarli. Researchers want to see how safe the drug is over time and how it affects liver function and overall health. Participants will be monitored for side effects, changes in liver tests,…
Matched conditions: ALAGILLE SYNDROME
Phase: PHASE4 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New drug shows promise for rare liver disease itching
Symptom relief Recruiting nowThis study looks at the long-term safety and effectiveness of odevixibat for people with Alagille syndrome, a rare genetic disorder that affects the liver and other organs. The main goal is to see if the drug can safely reduce severe itching and improve quality of life. Participa…
Matched conditions: ALAGILLE SYNDROME
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC